Beam Therapeutics (BEAM)Chief Legal Officer sold ~$340K
Christine Bellon, Chief Legal Officer at Beam Therapeutics, sold ~$340K of Beam Therapeutics shares.
- ~$340K
- Approx. value · 10K sh @ $34.00
- 103K
- Holds after · shares reported
- Traded
- Feb 14, 2025
- Filed
- Feb 19, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 2, 2025Insider · 2 peopleInsiders: 2 sales (~$58K)
- Jan 30, 2025Insider · 1 personInsiders: 2 sales (~$802K)
- Feb 14, 2025 · this disclosureInsiderOfficer sold ~$340K of BEAM shares in the open market
What came next
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Beam Therapeutics
For Beam Therapeutics, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 5 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BEAM page.
Other recent filings by Christine Bellon, Chief Legal Officer
- SEC Form 4 at Beam Therapeutics (BEAM)Apr 4, 2025
- SEC Form 4 at Beam Therapeutics (BEAM)Jan 6, 2025
- SEC Form 4 at Beam Therapeutics (BEAM)Oct 2, 2024
The full history of Christine Bellon, Chief Legal Officer is on the profile page.
How this filing works
Other disclosures at Beam Therapeutics
- SEC Form 4Oct 2, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
Everything OQRO holds on this company is on its BEAM page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
